文献速递妇科生殖医学

子宫肌瘤剔除术与抗苗勒管激素水平及卵巢储备的关联

Association of Myomectomy With Anti-Müllerian Hormone Levels and Ovarian Reserve.
PubMed 文献 · Obstet Gynecol · 2022-11-02

本前瞻性队列研究纳入111例接受子宫肌瘤剔除术的患者,比较开腹(使用止血带)与微创(使用血管加压素)术后血清抗苗勒管激素(AMH)水平变化。结果显示术后2周AMH显著下降,开腹组下降更明显,但3个月和6个月时均恢复至基线水平,提示肌瘤剔除术对卵巢储备无长期影响。

要点

  • 术后2周血清AMH较基线显著下降(平均变化-0.30 ng/mL,95%CI -0.48至-0.120 ng/mL,P=.002)。
  • 开腹肌瘤剔除术与术后2周AMH下降显著相关(开腹 vs 微创:β=-0.63±0.22 ng/mL,P=.007)。
  • 术后3个月和6个月AMH与基线无显著差异,提示无长期卵巢储备影响。

核心结论

  • 子宫肌瘤剔除术与术后早期AMH一过性下降相关,尤其在使用止血带的开腹手术后。
  • 术后3个月AMH恢复至基线水平,提示肌瘤剔除术对卵巢储备无长期影响,即使使用止血带减少出血。

研究设计与样本

  • 前瞻性队列研究,纳入111例接受子宫肌瘤剔除术的患者(平均年龄37.9±4.7岁),其中65例开腹(使用止血带)、46例微创(机器人辅助或腹腔镜,使用血管加压素)。
  • 术前及术后2周、3个月、6个月采集血清AMH水平,87例提供随访数据。
  • 采用多变量线性回归评估手术路径对各时间点AMH变化的影响,并分别对开腹组和微创组进行亚组分析。

主要发现

  • 术后2周血清AMH较基线显著下降(平均变化-0.30 ng/mL,95%CI -0.48至-0.120 ng/mL,P=.002);术后3个月和6个月无显著差异。
  • 多变量线性回归显示,开腹肌瘤剔除术与术后2周AMH下降显著相关(开腹 vs 微创:β=-0.63±0.22 ng/mL,P=.007),术后3个月和6个月无显著关联。
  • 亚组分析:开腹组术后2周AMH较基线显著下降(平均变化-0.46 ng/mL,95%CI -0.69至-0.25 ng/mL,P<.001),术后3个月和6个月无显著差异;微创组各术后时间点与基线均无显著差异。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess whether open and minimally invasive myomectomy are associated with changes in postoperative ovarian reserve as measured by serum anti-müllerian hormone (AMH) level. METHODS: This prospective cohort study included patients who were undergoing open abdominal myomectomy that used a tourniquet or minimally invasive (robot-assisted or laparoscopic) myomectomy that used vasopressin. Serum AMH levels were collected before the procedure and at 2 weeks, 3 months, and 6 months after surgery. The mean change in AMH level at each postsurgery timepoint was compared with baseline. The effect of surgical route on the change in AMH level at each timepoint was assessed by using multivariable linear regression. A subanalysis evaluated postoperative changes in AMH levels among the open myomectomy and minimally invasive myomectomy groups individually. RESULTS: The study included 111 patients (mean age 37.9±4.7 years), of whom 65 underwent open myomectomy and 46 underwent minimally invasive myomectomy. Eighty-seven patients contributed follow-up data. Serum AMH levels declined significantly at 2 weeks postsurgery (mean change -0.30 ng/mL, 95% CI -0.48 to -0.120 ng/mL, P=.002). No difference was observed at 3 months or 6 months postsurgery. On multiple linear regression, open myomectomy was significantly associated with a decline in AMH level at 2 weeks postsurgery (open myomectomy vs minimally invasive myomectomy: β=-0.63±0.22 ng/mL, P=.007) but not at 3 months or 6 months. Subanalysis revealed a significant decline in mean serum AMH levels in the open myomectomy group at 2 weeks (mean change -0.46 ng/mL, 95% CI -0.69 to -0.25 ng/mL, P<.001) postsurgery but not at three or 6 months. In the minimally invasive myomectomy group, no significant differences in mean AMH levels were detected between baseline and any postoperative timepoint. CONCLUSION: Myomectomy is associated with a transient decline in AMH levels in the immediate postoperative period, particularly after open surgery in which a tourniquet is used. Anti-müllerian hormone levels returned to baseline by 3 months after surgery, indicating that myomectomy is not associated with a long-term effect on ovarian reserve, even with the use of a tourniquet to decrease blood loss. FUNDING SOURCE: This study was funded in part by a Roche Diagnostics Investigator-Initiated Study Grant.

来源:Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Aharon D, Sekhon L, Getrajdman C, et al. Association of Myomectomy With Anti-Müllerian Hormone Levels and Ovarian Reserve. Obstet Gynecol. 2022. PMID: 36441930. doi:10.1097/AOG.0000000000004983

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。